{
    "summary": "The 'Small Biotech Innovation Act' amends the Social Security Act to exempt certain research and development-intensive small biotech manufacturers from the Medicare drug price negotiation program. This exemption applies to manufacturers with five or fewer qualifying single source drugs and who invest a specified percentage of their net revenue in research and development. The bill defines qualifications, establishes an application process, and outlines dispute resolution mechanisms for manufacturers seeking the exemption.",
    "tags": [
        "Healthcare",
        "Social security",
        "Consumer protection",
        "Economic recovery",
        "Job creation"
    ],
    "category": "Healthcare & Public Health"
}